NATCO Pharma Wins Patent War against Teva Pharmaceuticals.

Hyderabad based-Natco Pharma has won a patent battle against Israeli drug giant Teva Pharmaceuticals, over Copaxone, a drug used to treat multiple sclerosis. Natco markets Copaxone (Glatiramer Acetate) used in the treatment of relapsing-remitting multiple sclerosis — in the US market. The drug’s patent to Teva is set to expire in May. Teva appealed The…